Strain imaging is an echocardiographic analysis technique that quantifies how much the heart muscle deforms as it contracts, turning the subjective eyeball assessment of wall motion into a number. Rather than judging whether a segment looks like it moves, strain measures the percentage by which the muscle shortens, giving an earlier and more reproducible signal of dysfunction than ejection fraction alone.
For a buyer, the key point is that strain imaging is software, not hardware. It is a licensed analysis package that runs on an echocardiography machine or a separate workstation, and its main procurement traps are vendor variability and licensing — not the transducer.
Why eyeballing wall motion was not enough
For decades,s wall motion was read by eye, ye and ejection fraction was the headline number for pump function. Both miss early disease: a heart can hold a normal ejection fraction while the longitudinal muscle fibres are already failing. Strain imaging exposes that gap. By measuring deformation directly, it flags dysfunction before ejection fraction drops, which is why it has moved from research tool to routine report line in many services.
How speckle-tracking strain works
The dominant method is two-dimensional speckle-tracking. Ultrasound images carry a natural speckle pattern — small, stable acoustic markers within the muscle. The software identifies these speckles and follows them frame to frame through the cardiac cycle, and from how far they move relative to each other, it derives strain, the percentage change in length of a segment. Because it tracks the tissue itself rather than a Doppler angle, speckle-tracking is largely angle-independent, a key advantage over the older tissue-Doppler strain it replaced.
Global longitudinal strain, the headline number
The measurement most reports quote is global longitudinal strain, or GLS: the average shortening of the left ventricle along its long axis, taken from standard apical views. It is expressed as a negative percentage — muscle shortens, so a more negative value means better function — and the exact normal range depends on the vendor and should be read against the system's own reference. Results are shown as a colour bull's-eye map that splits the ventricle into segments, making a regional problem easy to spot at a glance.
Where strain imaging changes management
Strain imaging has found its clearest role in cardio-oncology, where serial GLS can detect the early cardiotoxicity of some cancer drugs before ejection fraction falls, prompting earlier review. It also helps flag early heart failure, characterise infiltrative and hypertrophic disease by their regional strain patterns, and inform timing decisions in valve disease. In each case, the value is the same: an earlier, quantified, reproducible read of muscle function that a visual assessment cannot match.
The vendor-variability problem every buyer must understand
This is the single most important procurement point. GLS values are not perfectly interchangeable between manufacturers — different tracking algorithms produce slightly different numbers on the same heart. Industry standardisation efforts have narrowed the gap, but a patient monitored over time should be followed on the same vendor's software to keep serial measurements comparable. For a department running mixed equipment that has real consequences: either standardise the analysis vendor, or use a vendor-neutral workstation that applies one consistent algorithm across images from any machine.
On-cart analysis versus a vendor-neutral workstation
Strain can be measured two ways. On-cart packages run the manufacturer's algorithm directly on the echo machine, quick and integrated but tied to that vendor. A separate vendor-neutral analysis workstation ingests DICOM images from any machine and applies one algorithm, which solves the mixed-fleet comparability problem and centralises reporting, at the cost of another system and licence. Which suits you depends on whether your fleet is single-vendor or mixed, and on how much serial follow-up you do.
Image quality: strain is only as good as the loop
Speckle-tracking needs good images and an adequate frame rate, high enough to track speckles between frames without blurring but not so high that line density suffers. Poor endocardial definition, foreshortened apical views,s or dropped frames all corrupt the measurement. Strain therefore rewards good acquisition technique and a capable base machine; it cannot rescue a poor study. When you licence strain, check the base echocardiography machines feeding it can deliver the image quality the algorithm needs.
Regulation and standards for strain software
Strain imaging is software, and analysis software that informs clinical decisions is regulated as a medical device — it must carry UKCA or CE marking under the oversight of the Medicines and Healthcare products Regulatory Agency at mhra.gov.uk. The echocardiography machine that acquires the images is medical electrical equipment built to IEC 60601-1 with the ultrasonic particular standard IEC 60601-2-37. Confirm the strain package's own regulatory status and software version, because validation and updates matter as much here as electrical safety does for the hardware. This guide is compiled from manufacturer documentation and UK regulatory guidance for procurement teams.
Reporting, integration and running costs
Strain results need to land in the report and the record, so confirm the package exports its bull's-eye map and GLS values into your structured reporting and PACS. Costs are dominated by licensing — often per-machine or subscription — plus training, since reproducible strain depends heavily on consistent operator technique. Factor in the workstation if you go vendor-neutral. Compare licensing models across suppliers and use MediGear to compare verified suppliers.
Strain and ejection fraction, side by side
Strain imaging does not replace ejection fraction; the two work together. Ejection fraction remains the familiar, widely understood measure of overall pump function and drives many treatment thresholds. Strain adds sensitivity, catching a fall in longitudinal function while ejection fraction still reads normal, and it localises the problem on the bull's-eye map. In practice,ce a report may carry both: a preserved ejection fraction with a quietly worsening global longitudinal strain is exactly the early-warning pattern that makes strain worth having. For a buyer, that means strain is an addition to the reporting toolkit, justified where earlier or more reproducible detection changes what the clinical team does next.
Setting up strain: training and competency
Introducing strain imaging is a training project as much as a purchase. Reproducible results depend on consistent acquisition — well-aligned apical views at the right frame rate — and on operators applying the tracing the same way. A department adding strain should plan for supervised training, a period of double-reading against experienced readers, and agreed local protocols for which views and which segments feed the global longitudinal strain value. Without that groundwork, the numbers scatter and clinicians lose trust in them, especially in serial cardio-oncology monitoring where a small real change must be told apart from measurement noise. Budget the training time and build local reference values alongside the licence, not after it.
Beyond the left ventricle: RV and atrial strain
Global longitudinal strain of the left ventricle is the headline, but strain imaging is not limited to it. Right-ventricular free-wall strain gives a reproducible measure of a chamber that is notoriously hard to assess by eye and by ejection fraction, and it is increasingly used in pulmonary and right-heart disease. Left atrial strain is an emerging marker of raised filling pressure and atrial function. These measures use the same speckle-tracking principle but need dedicated modules and their own normal ranges. If your service is likely to want them, check whether the package includes RV and atrial strain or charges for them separately, so you are not buying twice.
Automation, reproducibility and AI-assisted analysis
Reproducibility is the recurring challenge with strain imaging, because manual tracing introduces operator variability. Vendors have responded with automated endocardial border detection and, increasingly, AI-assisted contouring that proposes the tracing for the operator to accept or correct. Done well, automation speeds reporting and tightens consistency between sonographers, which is exactly what serial monitoring in cardio-oncology needs. It does not remove the need for a trained eye: a poor image or a foreshortened view still misleads the algorithm, so the operator must review every result. Ask any strain vendor how their automation performs on imperfect studies and how the output is validated.
Before you licence strain imaging: checklist
-
Speckle-tracking package validated for the analyses you need, starting with global longitudinal strain.
-
A clear plan for vendor consistency — single vendor or a vendor-neutral workstation for serial follow-up.
-
Base echo machines capable of the frame rates and image quality strain needs.
-
Licensing model — per-machine, concurrent or subscription — costed over the contract term.
-
UKCA or CE marking for the analysis software and a clear update and validation path.
-
Export of GLS values and bull's-eye maps into structured reporting and PACS.
-
Operator training to keep measurements reproducible between sonographers.
The verdict on strain imaging
Strain imaging turns wall motion from a judgement call into a measurement, catching muscle dysfunction earlier than ejection fraction and adding real value in cardio-oncology and heart failure. Because it is software, buy it as software: mind the vendor variability, the licensing,g and the workflow, not just the algorithm's headline claims. If you are adding strain to your echo service, MediGear can help you compare suppliers and licensing on equal terms.
Disclaimer
This article is for informational purposes only. It is published by MediGear (medigear.uk) for general information and procurement guidance, and is not clinical, diagnostic, treatment, technical, engineering, legal or regulatory advice, nor a product endorsement, guarantee or substitute for professional assessment. MediGear does not provide medical consultations. Buyers should consult their clinical, biomedical, estates and regulatory contacts, and the manufacturer's documentation, and independently verify all specifications, certifications, compatibility and suitability before purchase. Specifications, certifications and availability are correct at the time of publication and may change without notice. MediGear is a medical-equipment distributor and does not sell medicines or pharmaceutical products.
